fda declaratory order semaglutide shortage resolved feb 21 2025 The Removes from the Drug List FDA declares semaglutide shortage over

PIONEER researchers reported that oral semaglutide, the first GLP-1 receptor agonist for oral administration, reduced CV death and all-cause mortality by nearly 50 percent versus placebo after a median follow-up of 15.9 months

Stay well hydrated, as dehydration is the fastest path to constipation on these medications

This is relevant to the Strive Pharmacy conversation because the compounded tirzepatide they produce should, in theory, activate both of these pathways identically to brand-name Mounjaro

Indias pharmaceutical ecosystem blends affordability with regulatory strength , giving distributors confidence to enter the GLP1 market with reduced risk and higher margins